fluorodeoxyglucose f18 has been researched along with Cancer of Endometrium in 133 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 21 (15.79) | 29.6817 |
2010's | 86 (64.66) | 24.3611 |
2020's | 26 (19.55) | 2.80 |
Authors | Studies |
---|---|
Dejanovic, D; Elgaard, T; Loft, A; Mosgaard, BJ | 1 |
Bergamini, A; Bettinardi, V; Bezzi, C; Bocciolone, L; Candiani, M; Candotti, G; De Cobelli, F; Fallanca, F; Gianolli, L; Gnasso, C; Ironi, G; Mangili, G; Mapelli, P; Picchio, M; Rancoita, PMV; Sant'Angelo, M; Scifo, P; Taccagni, GL | 1 |
Li, L; Li, Y; Xiao, L | 1 |
Imajo, M; Ishibashi, M; Kanenishi, K; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tanaka, T; Tsuruta, T; Yamamoto, Y | 1 |
Kiyono, Y; Makino, A; Mori, T; Okazawa, H; Tsujikawa, T; Tsuyoshi, H; Yoshida, Y | 1 |
Cui, Y; Du, B; Li, X; Li, Y; Ma, Y | 1 |
Araz, M; Bakırarar, B; Ortaç, UF; Soydal, Ç; Taşkın, S; Varlı, B | 1 |
He, L; Jiang, L; Tan, X; Yao, X; Yuan, H; Zeng, B; Zhang, H | 1 |
Has Simsek, D; Kiran, MY; Kuyumcu, S; Sanli, Y | 1 |
Akovali, B; Bese, T; Bicer, E; Demirkiran, F; Kabasakal, L; Tetikli Kosuk, A; Turan, H | 1 |
He, L; Jiang, L; Shang, Y; Sun, X; Yao, X; Zeng, B; Zhang, Q; Zhu, L | 1 |
Bao, W; Gu, S; Pan, YQ; Wang, M; Yang, Y | 1 |
Erdemoglu, E; Erdogan, M; Evrimler, Ş; Hanedan, C; Şengül, SS | 1 |
Cheng, MH; Li, J; Li, X; Liu, DD; Peng, F; Qin, L; Xie, L | 1 |
Chow, DZ; Kilcoyne, A; Lee, SI | 1 |
Benedetti Panici, P; Di Donato, V; Di Pinto, A; Musella, A; Palaia, I; Petriglia, G; Santangelo, G | 1 |
Budak, E; Yanarateş, A | 1 |
Koizumi, M; Koyama, M; Sugiura, Y; Terauchi, T | 1 |
Chino, Y; Kurokawa, T; Okazawa, H; Shinagawa, A; Tsujikawa, T; Tsuyoshi, H; Yamada, S; Yoshida, Y | 1 |
Altin, D; Ersöz, CC; Ortaç, F; Soydal, Ç; Taşkin, S; Varli, B | 1 |
Dybvik, JA; Fasmer, KE; Gulati, A; Haldorsen, IS; Krakstad, C; Salvesen, Ø; Trovik, J; Ytre-Hauge, S | 1 |
Bonacina, M; Buda, A; Crivellaro, C; De Bernardi, E; Delle Marchette, M; Di Martino, G; Elisei, F; Fruscio, R; Giuliani, D; Gotuzzo, I; Grassi, T; Guerra, L; Landoni, C; Landoni, F; Magni, S; Messa, C; Monaco, L | 1 |
Fan, Q; Su, M; Sun, J; Tian, R | 1 |
Davis, MR; Del Carmen, MG; Feltmate, CM; Goodman, A; Growdon, WB; Horowitz, NE; Lee, SI; St Laurent, JD | 1 |
Cen, B; Chen, Y; Liu, L; Wang, Y; Xu, T | 1 |
El-Rassi, Z; Haddad, L; Jabbour, T; Raad, RA | 1 |
Berg, HF; Bozickovic, O; Engerud, H; Forsse, D; Haldorsen, IS; Halle, MK; Hoivik, EA; Krakstad, C; Trovik, J; Werner, HMJ; Woie, K | 1 |
Aune, G; Hagen, B; Nordskar, NJ; Ogarkov, A; Salvesen, Ø; Vesterfjell, EV | 1 |
Fang, XH; Gai, QZ; Gao, Z; Li, GY; Lv, YB; Zhang, DQ | 1 |
Ahlström, H; Bergman, A; Jónsdóttir, B; Poromaa, IS; Ripoll, MA; Silins, I; Stålberg, K | 1 |
Catalano, OA; Kilcoyne, A; Lee, SI; Sertic, M | 1 |
Chae, SY; Choi, HJ; Kim, HO; Kim, YT; Lee, JJ; Nam, JH; Park, JY; Song, IH; Sung, CO | 1 |
Narayanan, P; Sahdev, A | 1 |
Hess, S; Jochumsen, KM; Lund, AA; Vilstrup, MH | 1 |
Atri, M; Bandos, AI; Gee, MS; Gold, MA; Lee, SI; Mannel, RS | 1 |
Bhosale, PR; Devine, C; Faria, S; Javadi, S; Korivi, BR; Viswanathan, C | 1 |
D'Amico, D; Fonti, R; Salvatore, B | 1 |
Minato, H; Sasagawa, T; Shibata, T; Takagi, H; Takahashi, T | 1 |
Huynh, KN; Nguyen, BD; Wu, KJ | 1 |
Ohmichi, M; Tanaka, T; Terai, Y; Yamada, T; Yamamoto, K | 1 |
Aubard, Y; Ceuca, A; Deluche, E; Gauthier, T; Lacorre, A; Legros, M; Margueritte, F; Mbou, VB; Monteil, J; Sallee, C; Tardieu, A | 1 |
Hu, Y; Luo, R; Shi, H; Xiu, Y; Yin, H | 1 |
Hu, J; Wang, Y; Xue, F; Yan, Y; Zang, Y; Zhang, K | 1 |
Aloia, TA; Chasen, B; Dioun, S; Erwin, W; Fleming, N; Frumovitz, M; Lu, KH; Ramirez, PT; Soliman, PT; Stewart, KI; Westin, SN; Wong, F | 1 |
Basso, SM; Bertozzi, S; Capobianco, G; Lumachi, F; Pasqual, EM; Re, GL; Santeufemia, DA; Tumolo, S | 1 |
Buda, A; Crivellaro, C; De Ponti, E; Elisei, F; Fruscio, R; Guerra, L; Messa, C; Montanelli, L; Pirovano, C; Signorelli, M | 1 |
Ebina, Y; Kanda, T; Kitajima, K; Maeda, T; Miyahara, Y; Suenaga, Y; Sugimura, K; Takahashi, S; Ueno, Y; Yamada, H | 1 |
Cheon, GJ; Chung, HH; Kim, HS; Kim, JW; Lee, I; Park, NH; Song, YS | 1 |
Hao, H; Hirota, S; Ikeda, Y; Inoue, K; Kawata, S; Oku, N; Tsubamoto, H | 1 |
Hasanzadeh, M; Kadkhodayan, S; Kakhki, VR; Sadeghi, R; Shahriari, S; Treglia, G; Yousefi, Z; Zakavi, SR | 1 |
Domaracki, P; Grabiec, M; Marszałek, A; Małecki, B; Sadłecki, P; Walentowicz, P; Walentowicz-Sadłecka, M | 1 |
Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, DY; Lee, JJ; Lee, SW; Nam, JH; Park, JY; Shim, SH | 1 |
Davoodi, R; Ghooshkhanei, H; Sabouri, G; Sadeghi, R; Treglia, G | 1 |
Adachi, M; Aoki, D; Banno, K; Iida, M; Kisu, I; Masuda, K; Nakamura, K; Nogami, Y; Tanaka, K; Tominaga, E; Umene, K | 1 |
Boers-Sonderen, MJ; de Geus-Oei, LF; Desar, IM; Ottevanger, PB; Oyen, WJ; van der Graaf, WT; van Herpen, CM | 1 |
Choi, OH; Jeon, HN; Jo, MS; Kim, GH; Kim, SJ; Suh, DS; Yun, MS | 1 |
Grabiec, M; Malkowski, B; Marszalek, A; Pietrzak, T; Sadlecki, P; Walentowicz, P; Walentowicz-Sadlecka, M | 1 |
Cheon, GJ; Chung, HH; Kim, HS; Kim, JW; Park, NH; Song, YS | 1 |
Cho, YL; Chong, GO; Hong, DG; Jeong, SY; Lee, DW; Lee, YH; Lee, YS; Park, JY | 1 |
Aoki, D; Banno, K; Iida, M; Irie, H; Kisu, I; Masugi, Y; Murakami, K; Nogami, Y; Okuda, S; Tanaka, K; Tominaga, E | 1 |
Hattori, N; Hirata, K; Kato, F; Magota, K; Manabe, O; Mimura, R; Sakuragi, N; Sudo, S; Sugimori, H; Tamaki, N | 1 |
Boonya-ussadorn, T; Choi, WH; Chung, SK; Hyun, J; Kim, SH; Yoo, IeR | 1 |
Ge, J; Guan, Y; Zhang, X; Zuo, C | 1 |
Feng, R; Li, F; Luo, Y | 1 |
Chen, P; Huang, Q; Jiang, M; Sun, L; Wu, H | 1 |
Bernshaw, D; Drummond, E; Hicks, RJ; Narayan, K; Simcock, B; Wells, E | 1 |
Ebina, Y; Kanda, T; Kitajima, K; Kubo, K; Maeda, T; Okunaga, T; Sofue, K; Suenaga, Y; Sugimura, K; Tamaki, Y; Ueno, Y; Yamada, H | 1 |
Chang, WC; Chen, BB; Chen, CA; Chen, CH; Chen, XJ; Cheng, WF; Chiang, YC; Sheu, BC; Shih, IL; Shih, TT; Torng, PL; Tseng, YH; Wei, LH; Wei, SY; Yen, ML; Yen, RF | 1 |
Biermann, M; Bjørge, L; Haldorsen, IS; Husby, JA; Magnussen, IJ; Reitan, BC; Salvesen, HB; Salvesen, ØO; Trovik, J | 1 |
Brekke, N; Fonnes, T; Haldorsen, IS; Kopperud, R; Krakstad, C; McCormack, E; Pavlin, T; Popa, M; Rygh, CB; Salvesen, HB; Visser, NC | 1 |
Arsenault, F; Turcotte, É | 1 |
Cho, A; Kang, WJ; Kim, HJ; Kim, YT; Yun, M | 1 |
Bollineni, VR; Bollineni-Balabay, O; Haldorsen, IS; Salvesen, HB; Ytre-Hauge, S | 1 |
Arnulfo, A; Brambilla, M; Buemi, F; Carriero, A; Cassarà, A; Matheoud, R; Sacchetti, GM; Stecco, A | 1 |
Aoki, D; Banno, K; Fujii-Nishimura, Y; Hibi, T; Morishima, Y; Murakami, K; Nogami, Y; Sugiyama, H; Susumu, N; Suzuki, A; Yamada, T | 1 |
Bernardini, MQ; Ferguson, SE; Halankar, J; McVey, R; Metser, U | 1 |
Erkaya, S; Güngör, T; Öz, M; Özgü, BS; Özgü, E; Yıldız, Y | 1 |
Berg, A; Bjørge, L; Bjørnerud, A; Fasmer, KE; Haldorsen, IS; Halle, MK; Hoivik, EA; Husby, JA; Krakstad, C; Mauland, KK; Salvesen, HB; Tangen, IL; Trovik, J; Werner, HM; Woie, K; Ytre-Hauge, S | 1 |
Arvas, M; Aydin, O; Bese, T; Demirayak, G; Demirkiran, F; Hallac, M; Ilvan, S; Kahramanoglu, I; Sal, V; Tokgozoglu, N; Turan, H; Vatankulu, B | 1 |
İbiş, E; Kahraman, A; Konuralp Atakul, B; Koyuncu, K; Ortac, F; Soydal, Ç; Sükür, YE; Taşkın, S | 1 |
Fanfani, F; Ferrandina, G; Gentileschi, S; Mattoli, MV; Palluzzi, E; Pennacchia, I; Scambia, G; Valentini, AL; Zannoni, G | 1 |
Ali, S; Atri, M; Dehdashti, F; DiSilvestro, P; Gold, M; King, SA; Koh, WJ; Lee, SI; Mannel, RS; Marques, H; Moxley, KM; Pearl, M; Plante, M; Zhang, Z; Zhou, X | 1 |
Adachi, K; Arimoto, T; Eguchi, S; Fujii, T; Fujikawa, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M | 1 |
Kuang, A; Ma, H; Shen, G; Su, M; Wan, Y | 1 |
Lee, SI; Russell, AH | 1 |
Aksu, G; Altun, E; Bilici, A; Karci, E; Ozkara, SK; Ustaalioglu, BB; Uygun, K | 1 |
Liu, Y | 1 |
Buda, A; Dell'Anna, T; Guerra, L; Mangili, G; Messa, C; Picchio, M; Signorelli, M; Sironi, S | 1 |
Fujibayashi, Y; Kiyono, Y; Kobayashi, M; Kotsuji, F; Kudo, T; Kurokawa, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
Hiramatsu, Y; Hongo, A; Kanazawa, S; Kodama, J; Nakamura, K; Okumura, Y | 1 |
De Marzi, P; Giovacchini, G; Mangili, G; Mapelli, P; Messa, C; Picchio, M; Samanes Gajate, AM; Sigismondi, C; Sironi, S; Spinapolice, EG; Viganò, R | 1 |
Enomoto, T; Hatazawa, J; Higuchi, I; Imaizumi, M; Inoue, A; Isohashi, K; Kato, H; Kimura, T; Nakajo, K; Shimosegawa, E; Tatsumi, M | 1 |
Abikhzer, G; Makis, W; Stern, J | 1 |
Arellano, RS; Flanders, VL; Gervais, DA; Lee, SI; Mueller, PR | 1 |
Hong, L; Li, HB; Li, Y; Wang, JL; Wang, Q; Yue, MG | 1 |
Choi, SC; Kim, BI; Kim, BJ; Kim, K; Kim, MH; Kim, Y; Lee, ED; Lee, KH; Park, SI; Ryu, SY | 1 |
Ho, L; Seto, J; Sheth, S | 1 |
Fujibayashi, Y; Kiyono, Y; Kotsuji, F; Kudo, T; Kurokawa, T; Okazawa, H; Tsujikawa, T; Yoshida, Y | 1 |
Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K | 1 |
Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Park, NH; Song, YS | 1 |
Avril, N; Gourtsoyianni, S; Reznek, R | 1 |
Fournet, S; Giacalone, PL; Rathat, G; Rouleau, C | 1 |
Fujii, S; Hamanaka, Y; Hara, T; Hayashida, K; Higashi, T; Konishi, I; Nakamoto, Y; Saga, T; Suga, T; Tatsumi, M; Togashi, K | 1 |
Ortaç, F; Taşkın, S | 1 |
Ahn, BC; Hong, CM; Jeong, SY; Kang, S; Kim, HW; Lee, HJ; Lee, J; Lee, SW; Song, BI | 1 |
Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K | 1 |
Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Kwon, HW; Park, NH; Song, YS | 1 |
Carpentier, P; Kolesnikov-Gauthier, H | 1 |
Chang, MC; Chen, JH; Cheng, KY; Kao, CH; Liang, JA; Yang, KT | 1 |
Kimura, H; Kiyono, Y; Maeda, H; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
Kita, M; Kitajima, K; Nakamoto, Y; Senda, M; Sugimura, K; Suzuki, K | 1 |
Chao, A; Chou, HH; Lai, CH; Liu, FY; Yen, TC | 1 |
Bal, C; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, P; Singh, H | 1 |
Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Loft, A; Lundvall, L; Nedergaard, L; Risum, S | 1 |
Kadkhodayan, S; Sadeghi, R; Shahriari, S; Treglia, G; Yousefi, Z | 1 |
Andersen, ES; Antonsen, SL; Asmussen, J; Berthelsen, AK; Christensen, IJ; Fagö-Olsen, CL; Fisker, R; Høgdall, C; Høgdall, E; Jochumsen, K; Loft, A; Nielsen, AL; Tabor, A | 1 |
Bal, C; Kumar, R; Malhotra, A; Reddy, RM; Sharma, P; Singh, H | 1 |
Lentz, SS | 1 |
Belhocine, T; De Barsy, C; Hustinx, R; Willems-Foidart, J | 1 |
Fujii, S; Fujita, T; Higashi, T; Higuchi, T; Ishimori, T; Kita, M; Konishi, J; Mamede, M; Mukai, T; Nakamoto, Y; Saga, T; Togashi, K; Yura, S | 1 |
Even-Sapir, E; Fishman, A; Grisaru, D; Lerman, H; Lievshitz, G; Metser, U | 1 |
Cerfolio, RJ; Chen, VK; Desmond, R; Eloubeidi, MA; Ojha, B; Syed, S | 1 |
Chang, TC; Chao, A; Chou, HH; Hsueh, S; Huang, HJ; Lai, CH; Ng, KK; Tsai, CS; Wu, TI; Yen, TC | 1 |
Grigsby, PW; Hope, AJ; Saha, P | 1 |
Fukuda, H; Hakamatsuka, T; Higano, S; Kaneta, T; Sato, A; Takahashi, S; Yamada, S; Yamada, T | 1 |
Chauhan, A; Dadparvar, S; Jana, S; Kumar, R | 1 |
Fujibayashi, Y; Kotsuji, F; Kurokawa, T; Okazawa, H; Sawamura, Y; Shinagawa, A; Yoshida, Y | 1 |
Chang, TC; Lai, CH; Yen, TC | 1 |
Chang, CC; Chen, YW; Hou, MF | 1 |
Chung, HH; Chung, JK; Kang, SB; Kang, WJ; Kim, JW; Park, NH; Song, YS | 1 |
Fukasawa, I; Hagiwara, S; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
Fukasawa, I; Inaba, N; Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K; Yamasaki, E | 1 |
Fujii, H; Ide, M; Kubo, A; Mochizuki, Y; Nakahara, T; Shohtsu, A; Takahashi, W; Yasuda, S | 1 |
18 review(s) available for fluorodeoxyglucose f18 and Cancer of Endometrium
Article | Year |
---|---|
PET Imaging of Estrogen Receptors for Gynecological Tumors.
Topics: Breast Neoplasms; Endometrial Neoplasms; Estradiol; Estrogens; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Receptors, Estrogen | 2022 |
FDG-PET for Assessment of Endometrial and Vulvar Cancer.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Vulvar Neoplasms | 2019 |
Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT.
Topics: Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
The role of
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2017 |
FDG-PET Assessment of Other Gynecologic Cancers.
Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2018 |
Diagnostic accuracy of preoperative
Topics: Abdomen; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Positron-Emission Tomography; Sensitivity and Specificity | 2013 |
Risk stratification and prognosis determination using (18)F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors | 2014 |
Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2014 |
High Diagnostic Value of 18F-FDG PET/CT in Endometrial Cancer: Systematic Review and Meta-Analysis of the Literature.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Recurrence | 2016 |
Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.
Topics: Abdominal Wall; Adenocarcinoma, Clear Cell; Adult; Antibiotics, Antineoplastic; Biopsy, Fine-Needle; Cell Transformation, Neoplastic; Cesarean Section; Cicatrix; Doxorubicin; Endometrial Neoplasms; Endometriosis; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Laparoscopy; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Ovariectomy; Pelvis; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Pregnancy; Rectus Abdominis; Salpingectomy | 2016 |
Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls.
Topics: Artifacts; Diagnosis, Differential; Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Ovary; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Spectrum of FDG PET/CT findings of uterine tumors.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Uterine Neoplasms | 2010 |
[FDG-PET and endometrial cancer].
Topics: Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Sensitivity and Specificity | 2012 |
18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Positron emission tomography in gynecological malignancies.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2006 |
Positron emission tomography imaging for gynecologic malignancy.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Cervical Neoplasms | 2007 |
10 trial(s) available for fluorodeoxyglucose f18 and Cancer of Endometrium
Article | Year |
---|---|
Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Endometrium; False Negative Reactions; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Salpingo-oophorectomy; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2019 |
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Polyethylene Glycols; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Treatment Outcome; Young Adult | 2014 |
Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors.
Topics: Adult; Aged; Aged, 80 and over; Computer Simulation; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Metabolic Clearance Rate; Middle Aged; Models, Biological; Multimodal Imaging; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Systems Integration; Whole Body Imaging | 2015 |
Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retroperitoneal Neoplasms; Risk Assessment; Sensitivity and Specificity | 2017 |
Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Estradiol; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Receptors, Estrogen; ROC Curve | 2009 |
The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reference Standards; Tumor Burden | 2010 |
Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.
Topics: Biological Transport; Endometrial Neoplasms; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Middle Aged; Positron-Emission Tomography | 2011 |
SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinosarcoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Linear Models; Lymph Node Excision; Middle Aged; Multimodal Imaging; Ovariectomy; Pelvis; Positron-Emission Tomography; Preoperative Care; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Assessment; ROC Curve; Salpingectomy; Tomography, X-Ray Computed | 2013 |
Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.
Topics: Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Menstrual Cycle; Middle Aged; Ovarian Neoplasms; Ovary; Postmenopause; Premenopause; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2004 |
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Topics: Aged; Biopsy, Fine-Needle; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Endometrial Neoplasms; Esophagoscopy; Female; Fluorodeoxyglucose F18; Granuloma; Histiocytosis; Histoplasmosis; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Lymphatic Diseases; Lymphatic Metastasis; Lymphoma; Male; Mediastinum; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Silicosis; Tomography, X-Ray Computed; Ultrasonography, Interventional; Urinary Bladder Neoplasms | 2005 |
105 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Endometrium
Article | Year |
---|---|
Rare Presentation of Late Complications After Undiagnosed Perforated Appendicitis Mimicking Recurrent Endometrial Carcinoma on 18F-FDG PET/CT.
Topics: Aged; Appendectomy; Appendicitis; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography | 2022 |
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2022 |
Solitary Splenic Metastasis From Endometrial Carcinoma Revealed on FDG PET/CT.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Splenic Neoplasms | 2022 |
Correlation of bone marrow 2-deoxy-2-[ 18 F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer.
Topics: Bone Marrow; C-Reactive Protein; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Extrauterine Endometrial Stromal Sarcoma Mimicking Colorectal Cancer With Metastases.
Topics: Colorectal Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Sarcoma, Endometrial Stromal | 2022 |
Radiomics analysis of uterine tumors in 18F-fluorodeoxyglucose positron emission tomography for prediction of lymph node metastases in endometrial carcinoma.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Uterine Neoplasms | 2022 |
Relationship between 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters and clinicopathology in endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Ki-67 Antigen; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden; Tumor Suppressor Protein p53 | 2022 |
18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.
Topics: Adenocarcinoma, Clear Cell; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
Association of mismatch repair deficiency in endometrial cancer with
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2023 |
Retrospective analysis of the
Topics: China; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Tumor Burden | 2023 |
Prognostic value of metabolic tumor volume and total lesion glycolysis assessed by 18F-FDG PET/CT in endometrial cancer.
Topics: Biological Transport; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Tumor Burden | 2019 |
Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Tumor Burden | 2019 |
Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Obesity, Morbid; Positron Emission Tomography Computed Tomography; Prospective Studies; Sentinel Lymph Node Biopsy | 2021 |
The value of PET/CT in determining lymph node metastasis of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity | 2019 |
Granulomatous Myositis Showing Fluctuating "Leopard-Man" Sign: A Case Report on FDG PET/CT Imaging.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Granuloma; Humans; Middle Aged; Myositis; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2019 |
FDG-PET/MRI with high-resolution DWI characterises the distinct phenotypes of endometrial cancer.
Topics: Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2020 |
Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
Topics: Aged; Algorithms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Intraoperative Period; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Risk Factors; Sentinel Lymph Node | 2020 |
Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve | 2020 |
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2020 |
Adrenal and Bone Metastases as the Initial Presentation of Endometrial Carcinoma Diagnosed by 18F-FDG PET/CT.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography | 2020 |
Prognostic Value of Preoperative Imaging: Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography to Computed Tomography Alone for Preoperative Planning in High-risk Histology Endometrial Carcinoma.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
18F-FDG PET/CT Findings of an Isolated Splenic Metastasis From Endometrial Adenocarcinoma.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Splenic Neoplasms | 2020 |
Inflammatory Myofibroblastic Tumor of the Liver Mimicking Metastasis on 18F-FDG PET/CT.
Topics: Diagnosis, Differential; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Myofibroblasts; Positron Emission Tomography Computed Tomography | 2021 |
Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Topics: Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Disease-Free Survival; Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Preoperative Care; Radiotherapy, Adjuvant; Risk Assessment | 2021 |
Initial experience with positron emission tomography/computed tomography in addition to computed tomography and magnetic resonance imaging in preoperative risk assessment of endometrial cancer patients.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Middle Aged; Positron Emission Tomography Computed Tomography | 2021 |
Validation of
Topics: Adult; Aged; Carcinoma; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Reproducibility of Results; Survival Analysis; Tomography, X-Ray Computed | 2021 |
The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate | 2017 |
Prognostic Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Endometrial Cancer: A Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies | 2017 |
Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Societies, Medical; United States; Uterine Neoplasms | 2018 |
Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT.
Topics: Aged; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
Association between 18F-fluorodeoxyglucose-PET/CT and histological grade of uterine endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphatase; Hexokinase; Humans; Japan; Linear Models; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve | 2018 |
Gastrointestinal: Caval tumor thrombus and duodenal metastasis from endometrial carcinoma.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endosonography; Female; Fluorodeoxyglucose F18; Humans; Neoplastic Cells, Circulating; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed; Vena Cava, Inferior | 2019 |
The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2018 |
Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of
Topics: Adult; Aged; Aorta; Area Under Curve; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2019 |
A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy as salvage treatment for a late wound recurrence of endometrial cancer.
Topics: Aged; Combined Modality Therapy; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Infusions, Parenteral; Laparotomy; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Salvage Therapy; Tomography, X-Ray Computed; Whole Body Imaging | 2013 |
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2013 |
Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2013 |
¹⁸F-Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma.
Topics: Adult; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Progesterone; Sarcoma, Endometrial Stromal | 2014 |
[SUVmax measured by 18F FDG PET/CT in the primary tumor in relation to clinical and pathological features of endometrial cancer].
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Poland; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden; Women's Health | 2013 |
Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Topics: Adult; Aged; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2014 |
Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2014 |
The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Prognosis; Tomography, X-Ray Computed | 2014 |
Preoperative PET/CT standardized FDG uptake values of pelvic lymph nodes as a significant prognostic factor in patients with endometrial cancer.
Topics: Adult; Aged; Biological Transport; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Middle Aged; Multimodal Imaging; Pelvis; Positron-Emission Tomography; Preoperative Period; Prognosis; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Hysterectomy; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
The efficacy of preoperative positron emission tomography-computed tomography (PET-CT) for detection of lymph node metastasis in cervical and endometrial cancer: clinical and pathological factors influencing it.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2015 |
FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Period; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Menopause; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Increased 18F-FDG uptake of widespread endometriosis mimicking ovarian malignancy.
Topics: Adult; Diagnosis, Differential; Endometrial Neoplasms; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
FDG PET/CT appearance of tumor thrombus of ovarian vessels masquerading as retroperitoneal fibrosis.
Topics: Adult; Diagnostic Errors; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Fibrosis; Sarcoma, Endometrial Stromal; Tomography, X-Ray Computed; Venous Thrombosis | 2015 |
18F-FDG PET/CT findings of a recurrent adenocarcinoma arising from malignant transformation of abdominal wall endometriosis.
Topics: Abdominal Wall; Adenocarcinoma; Adult; Cell Transformation, Neoplastic; Endometrial Neoplasms; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The role of positron emission tomography/computed tomography in planning radiotherapy in endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Survival Rate; Tomography, X-Ray Computed | 2015 |
Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Myometrium; Neoplasm Invasiveness; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Topics: Aged; Animals; Carcinoma; Cell Line, Tumor; Contrast Media; Dideoxynucleosides; Disease Models, Animal; Disease Progression; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Transplantation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
Endometriosis Under Estradiol Stimulation Imaged Using 18F-FDG and Its Control After Estradiol Cessation and Progesterone Hormonal Replacement.
Topics: Endometrial Neoplasms; Endometriosis; Estradiol; Female; Fluorodeoxyglucose F18; Hormone Replacement Therapy; Humans; Multimodal Imaging; Positron-Emission Tomography; Progesterone; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Preoperative Period; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.
Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Uterine Cervical Neoplasms | 2016 |
Anisakiasis mimics cancer recurrence: two cases of extragastrointestinal anisakiasis suspected to be recurrence of gynecological cancer on PET-CT and molecular biological investigation.
Topics: Adult; Anisakiasis; Diagnosis, Differential; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Endometrial Stromal; Tomography, X-Ray Computed | 2016 |
Intraoperative lymph node evaluation using 18F-FDG and a hand-held gamma probe in endometrial cancer surgery--a pilot study.
Topics: Aged; Cohort Studies; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Gamma Rays; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2016 |
Prognostic value of 18F-FDG PET/CT for identifying high- and low-risk endometrial cancer patients.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Turkey | 2016 |
Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.
Topics: Biomarkers; Cancer-Associated Fibroblasts; Cell Cycle; Cell Hypoxia; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
The Combination of Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Mapping in the Surgical Management of Endometrioid Endometrial Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Retrospective Studies; Sentinel Lymph Node | 2016 |
Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Topics: Adult; Aged; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Myometrium; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2017 |
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Blotting, Western; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Middle Aged; Neoplasm Staging; Neoplastic Stem Cells; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2017 |
FDG PET/CT Findings of an Isolated Abdominal Wall Metastasis of Endometrial Carcinoma 4 Years After Primary Surgery.
Topics: Abdominal Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2017 |
Performance of 18F-FDG PET/CT in endometrial cancer.
Topics: Adult; Aged; Aorta; Aortography; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
An unusual case of recurrent endometrial cancer presented with isolated cervical lymph node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2009 |
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2009 |
High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Hysterosalpingography; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterus | 2010 |
Incidental early stage endometrial adenocarcinoma diagnosed by F-18 FDG PET-CT, which was negative on ultrasound and nonspecific on MRI.
Topics: Adenocarcinoma; Aged; Endometrial Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Subtraction Technique; Tomography, X-Ray Computed; Ultrasonography | 2010 |
Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients.
Topics: Aged; Catheter Ablation; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Radiography, Interventional; Radiopharmaceuticals; Retroperitoneal Neoplasms; Retrospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[Value of (18)F-FDG imaging and serum tumor markers in the diagnosis of recurrent endometrial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; CA-125 Antigen; Cystadenocarcinoma, Serous; DNA-Binding Proteins; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Transcription Factors | 2010 |
Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2010 |
Intramuscular metastasis of endometrial carcinoma on FDG PET/CT.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Gynecological cancers.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms | 2011 |
False positive lymph node activity on positron emission tomography (PET/CT) due to hemostatic compresses.
Topics: Adenocarcinoma; Endometrial Neoplasms; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granuloma, Foreign-Body; Humans; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Surgical Sponges; Tomography, X-Ray Computed | 2011 |
Clinical value of FDG-PET for preoperative evaluation of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Preoperative Period; Retrospective Studies | 2011 |
Inguinal recurrence of early stage endometrial cancer after 7 months of surgical staging: the role of PET-CT in diagnosis and management.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2011 |
The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2012 |
Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FES.
Topics: Aged; Breast Neoplasms; Contrast Media; Endometrial Neoplasms; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Middle Aged; Neoplasms, Hormone-Dependent; Phenotype; Positron-Emission Tomography; Sensitivity and Specificity | 2012 |
Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.
Topics: Adult; Aged; Biological Transport; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Carcinoma endometrium: role of 18-FDG PET/CT for detection of suspected recurrence.
Topics: Adenocarcinoma; Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
Sister Mary Joseph nodule in endometrial carcinoma: detection with FDG PET/CT.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Radiography; Radionuclide Imaging; Sister Mary Joseph's Nodule | 2013 |
Endometrial carcinoma diagnosed by positron emission tomography: a case report.
Topics: Aged; Carcinoma; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms, Multiple Primary; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.
Topics: Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Recurrence; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Postoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
18F-FDG PET in the management of endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole Body Imaging | 2006 |
FDG-PET in carcinoma of the uterine cervix with endometrial extension.
Topics: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Cervix Uteri; Combined Modality Therapy; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
Prolapsed endometrial cancer: FDG PET/CT findings.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Prognosis; Prolapse; Radiopharmaceuticals; Subtraction Technique; Tomography, X-Ray Computed; Uterine Neoplasms | 2006 |
The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Incidental diagnosis of endometrial carcinoma in a patient with breast cancer by FDG PET/CT.
Topics: Adenocarcinoma; Breast Neoplasms; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings.
Topics: Adult; Aged; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Endometrial Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
Accuracy of 18F-FDG PET/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer.
Topics: Adult; Aged; Aorta; Aortography; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2008 |
F-18 FDG uptake in endometrial cancer.
Topics: Endometrial Neoplasms; Endometrium; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |